The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Scientists Figure Out How The Heart Develops From Frog Embryos
Using fluorescently-dyed cells migrating to the heart, scientists have teased apart important steps during embryonic development of the heart in frogs.
Injection Of Sema3E Protein Helps Reverse Blindness From Ischemic Retinopathy
Scientists have found potential ways to treat ischemic retinopathy, which is the degeneration of the retina due to loss of blood flow and one of the leading causes of blindness.
Soaring Food Prices Threaten to Push Millions Into Poverty
The Asian Development Bank estimates that an additional 64 million people will be pushed into extreme poverty this year, based on the $1.25 a day poverty line.
Sending Doctors To Heart Attack Patients Improves Outcomes
In large, traffic-congested cities, severe heart attack patients received treatment faster and had better long-term results when interventional physicians were brought to them instead.
Japan Approves Oral Factor Xa Inhibitor For Venous Thromboembolism
Daiichi Sankyo Co. has received its first marketing approval for LIXIANA® tablets by the Ministry of Health, Labor and Welfare in Japan.
Scientists To Monitor Shark Fin Trade Using DNA ‘Zip Codes’
Genetic differences among sharks may allow scientists to track the origin of the fins on sale in Asian markets, enabling better monitoring and management of these threatened predators.
Heart Disease, Stroke, Cancer and Diabetes Rising In Developing World
In 2008, 36.1 million people died from heart disease, stroke, chronic lung disease, cancer and diabetes, with 80 percent of cases occuring in low- and middle-income countries.
iCeutica Sale To Iroko Pharmaceuticals Finalized
Australian pharma iCeutica Inc. announced yesterday that it has finalized the sale of all of its shares to US partner Iroko Pharmaceuticals, LLC.
Bangalore-Based Biocon Sells Majority Stake In AxiCorp
Bangalore-based Biocon Ltd. will divest a majority stake in its German unit AxiCorp GmbH for $58 million.